\
&
Contact us
\
&
Contact us
Starts in 2 months from now
LocationNoordwijk (NL)
ESA Industry Space Days 2026 is a biennial event that aims to bring together around 2,500 participants for networking and business exchange across the European space ecosystem. The programme is designed to help attendees engage directly with ESA and industry representatives, build relationships with clients and partners, and discuss industrial cooperation and future developments.
The event also includes exhibition opportunities, with more than 200 booths available in the exhibition hall for organisations wishing to show products, services, and capabilities relevant to ESA missions and related industrial activities. According to the source text, the event is open to entities and investors from ESA Member States, Associate States, and Cooperating States.
Registration is now open via this Registration Link.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
